A detailed history of Arrowstreet Capital, Limited Partnership transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 104,951 shares of RDY stock, worth $8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
104,951
Previous 29,082 260.88%
Holding current value
$8 Million
Previous $2.02 Million 280.34%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $5.11 Million - $5.89 Million
75,869 Added 260.88%
104,951 $7.7 Million
Q4 2023

Feb 14, 2024

SELL
$64.27 - $69.9 $14.1 Million - $15.4 Million
-219,964 Reduced 88.32%
29,082 $2.02 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $6.3 Million - $7.41 Million
101,838 Added 69.18%
249,046 $16.7 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $7.85 Million - $9.29 Million
147,208 New
147,208 $9.29 Million
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $74,014 - $83,130
-1,447 Reduced 14.11%
8,805 $456,000
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $511,574 - $587,644
10,252 New
10,252 $537,000
Q4 2020

Feb 12, 2021

SELL
$62.61 - $71.29 $3.9 Million - $4.44 Million
-62,275 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$51.39 - $72.41 $7.04 Million - $9.93 Million
-137,082 Reduced 68.76%
62,275 $4.33 Million
Q2 2020

Aug 12, 2020

BUY
$39.55 - $54.65 $7.88 Million - $10.9 Million
199,357 New
199,357 $10.6 Million
Q3 2019

Nov 14, 2019

SELL
$34.82 - $39.26 $591,940 - $667,420
-17,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$36.05 - $42.76 $358,228 - $424,906
9,937 Added 140.69%
17,000 $637,000
Q1 2019

May 15, 2019

BUY
$35.77 - $40.57 $252,643 - $286,545
7,063 New
7,063 $286,000
Q3 2018

Nov 14, 2018

SELL
$29.25 - $36.73 $7.75 Million - $9.74 Million
-265,100 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$28.49 - $35.06 $7.55 Million - $9.29 Million
265,100 New
265,100 $8.54 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $12.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.